Pertuzumab Biosimilar, Endotoxin 0.05 EU/mg. Pertuzumab biosimilar CHO stable cell line is available for licensing to manufacture the pertuzumab biosimilar protein.The research grade pertuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1...
Cetuximab Biosimilar, Endotoxin 0.05 EU/mg. The research grade cetuximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Cetuximab biosimilar CHO stable cell line is available for licensing to...
Cetuximab Biosimilar, Mouse IgG2a. The research grade cetuximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Cetuximab biosimilar CHO stable cell line is available for licensing to manufacture...
Cetuximab Biosimilar, Mouse IgG1. The research grade cetuximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Cetuximab biosimilar CHO stable cell line is available for licensing to manufacture...
Cetuximab Biosimilar, Human IgG3. The research grade cetuximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Cetuximab biosimilar CHO stable cell line is available for licensing to manufacture...
Cetuximab Biosimilar, Human IgG2. The research grade cetuximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Cetuximab biosimilar CHO stable cell line is available for licensing to manufacture...
Denosumab Biosimilar, Human IgG1. Denosumab biosimilar CHO stable cell line is available for licensing to manufacture the denosumab biosimilar protein.The research grade denosumab biosimilar protein is for research use only (RUO). Recombinant human IgG2 isotype...
Cetuximab biosimilar L234A L235A P329G (LALAPG) Fc silent mutant (anti-human EGFR monoclonal antibody) is used for ELISA, neutralization, in vivo functional assays such as bioanalytical PK and ADA assays, and those in vitro and in...
